Pennsylvania part of $720 million national settlement against 8 opioid manufacturers

Pennsylvania has become part of a proposed nationwide settlement with eight drug manufacturers worth approximately $720 million.

"These funds come out of the pockets of companies that contributed to the nationwide addiction epidemic and into Pennsylvania communities," Attorney General Sunday said.

The eight companies in this settlement (Mylan, Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, Zydus) have agreed to a sign-on period for local governments to participate.

As of now Pennsylvania could receive up to $28 million, barring participation from local governments.

Below is the payment shares between the eight company defendants.

• Mylan (now part of Viatris): $284,447,916 paid over nine years
• Hikma: $95,818,293 paid over one to four years
• Amneal: $71,751,010 paid over 10 years
• Apotex: $63,682,369 paid in a single year
• Indivior: $38,022,450 paid over four years
• Sun: $30,992,087 paid over one to four years
• Alvogen: $18,680,162 paid in a single year
• Zydus: $14,859,220 paid in a single year

In addition to these payments, some of these settlements allow states to receive free medicine and pharmaceutical products or cash instead. 

Indivior has agreed to stop selling and manufacturing of any opioid product for the next ten years, and the other companies are prohibited from promoting opioids and from making medicine containing 40 mg of oxycodone per pill.